نتائج البحث - Wei-Ying Jen
- يعرض 1 - 8 نتائج من 8
-
1
Remote monitoring of marginalised populations affected by COVID-19: a retrospective review حسب Yen-Lin Chee, Stephanie Q Ko, Benjamin M Y Hooi, Chieh-Yang Koo, Daniel W P Chor, Zheng Jye Ling, Wei-Ying Jen
الحاوية / القاعدة BMJ Open (2020-12-01)احصل على النص الكامل
مقال -
2
PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes حسب Alexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, Kelly Chien, Koji Sasaki, Wei Ying Jen, Mahesh Swaminathan, Tapan Kadia, Courtney DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Hagop Kantarjian
الحاوية / القاعدة Haematologica (2025-07-01)احصل على النص الكامل
مقال -
3
Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell... حسب Roberta S. Azevedo, Wei-Ying Jen, Danielle Hammond, Fadi G. Haddad, Alexis Geppner, Ghayas C. Issa, Koji Sasaki, Jayastu Senapati, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia
الحاوية / القاعدة Haematologica (2025-06-01)احصل على النص الكامل
مقال -
4
A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AML حسب Noor Rashidha Binte Meera Sahib, Jameelah Sheik Mohamed, Masturah Bte Mohd Abdul Rashid, Jayalakshmi, Yihao Clement Lin, Yen Lin Chee, Bingwen Eugene Fan, Sanjay De Mel, Melissa Gaik Ming Ooi, Wei‐Ying Jen, Edward Kai‐Hua Chow
الحاوية / القاعدة Cancer Medicine (2024-11-01)احصل على النص الكامل
مقال -
5
A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM) حسب Chandramouli Nagarajan, Wei-Ying Jen, Melissa Ooi, Sanjay De Mel, Cinnie Soekojo, Sung Soo Yoon, Melinda Tan, Yunxin Chen, Xinhua Li, Yogesh Pokharkar, Shi Ning Tham, Nur Shahidah Binte Hashim, Neha Awasthi, Sarah M. Burkill, Brian Durie, Wee Joo Chng
الحاوية / القاعدة Blood Cancer Journal (2025-06-01)احصل على النص الكامل
مقال -
6
A Phase 2 study of CPX‐351 in combination with venetoclax in patients with newly diagnosed high‐risk acute myeloid leukemia حسب Wei‐Ying Jen, Jennifer Croden, Emmanuel Almanza‐Huante, Courtney DiNardo, Kelly Chien, Danielle Hammond, Wei Qiao, Yesid Alvarado, Lucia Masarova, Andres E. Quesada, Sherry Pierce, Alex Bataller, Guillermo Garcia‐Manero, Amin Alousi, Nicholas Short, Naval Daver, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia
الحاوية / القاعدة HemaSphere (2025-10-01)احصل على النص الكامل
مقال -
7
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy حسب Wei-Ying Jen, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Sa A. Wang, Wei Wang, Sanam Loghavi, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Alex Bataller, Samuel Urrutia, Omer S. Karrar, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short
الحاوية / القاعدة Blood Advances (2025-02-01)احصل على النص الكامل
مقال -
8
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003) حسب Jin Seok Kim, Yang Song, Wei-Ying Jen, C. S. Chim, Je-Jung Lee, Sung-Soo Yoon, Soo Chin Ng, Gin Gin Gan, Hiroshi Handa, Jae Hoon Lee, Kihyun Kim, Shigeki Ito, Jeffrey Shang-Yi Huang, Chang Ki Min, Melissa Ooi Gaik Ming, Sanjay de Mel, Cinnie Soekojo, Xinhua Li, Neha Awasthi, Yogesh Pokharkar, Brian GM Durie, Wee-Joo Chng
الحاوية / القاعدة Blood Cancer Journal (2025-10-01)احصل على النص الكامل
مقال
